Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (151-160 of 330) with videos related to

Pageof 33
Sort By:
Journal of the National Cancer Institute|May 26, 2020
Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and BeyondRachel A Freedman, Mina S Sedrak, Jennifer R Bellon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2025
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast CancerShom Goel, Bojana Jovanović, Xiangying Chu, et al.
NPJ Breast Cancer|March 4, 2025
Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastasesThomas Grinda, Stefania Morganti, Liangge Hsu, et al.
Breast Cancer Research and Treatment|October 5, 2024
Intracranial outcomes following neurosurgical resection in patients with brain metastases secondary to HER2-positive breast cancer versus other subtypesNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancerChiara Corti, Tianyu Li, Alyssa R Martin, et al.
Breast Cancer Research and Treatment|September 22, 2019
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastasesJosé Pablo Leone, Dan G Duda, Jiani Hu, et al.
JMIR Research Protocols|April 27, 2022
Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science-Based StudyAshley J Housten, Uzoma Charles Okere, Graham A Colditz, et al.
Breast Cancer Research and Treatment|June 9, 2016
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysisAntonio Di Meglio, Rachel A Freedman, Nancy U Lin, et al.
NPJ Precision Oncology|June 19, 2026
Clinical responses to trastuzumab deruxtecan in molecularly defined ependymomaL Nicolas Gonzalez Castro, Yi-Chien Wu, Jia-Ren Lin, et al.
NPJ Breast Cancer|April 4, 2024
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancerPaolo Tarantino, Julieta Leone, Carlos T Vallejo, et al.
Pageof 33

Showing results (151-160 of 330) with videos related to

Sort By:
Pageof 33
Journal of the National Cancer Institute|May 26, 2020
Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and BeyondRachel A Freedman, Mina S Sedrak, Jennifer R Bellon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2025
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast CancerShom Goel, Bojana Jovanović, Xiangying Chu, et al.
NPJ Breast Cancer|March 4, 2025
Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastasesThomas Grinda, Stefania Morganti, Liangge Hsu, et al.
Breast Cancer Research and Treatment|October 5, 2024
Intracranial outcomes following neurosurgical resection in patients with brain metastases secondary to HER2-positive breast cancer versus other subtypesNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancerChiara Corti, Tianyu Li, Alyssa R Martin, et al.
Breast Cancer Research and Treatment|September 22, 2019
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastasesJosé Pablo Leone, Dan G Duda, Jiani Hu, et al.
JMIR Research Protocols|April 27, 2022
Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science-Based StudyAshley J Housten, Uzoma Charles Okere, Graham A Colditz, et al.
Breast Cancer Research and Treatment|June 9, 2016
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysisAntonio Di Meglio, Rachel A Freedman, Nancy U Lin, et al.
NPJ Precision Oncology|June 19, 2026
Clinical responses to trastuzumab deruxtecan in molecularly defined ependymomaL Nicolas Gonzalez Castro, Yi-Chien Wu, Jia-Ren Lin, et al.
NPJ Breast Cancer|April 4, 2024
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancerPaolo Tarantino, Julieta Leone, Carlos T Vallejo, et al.
Pageof 33